How to find 10x stocks (and why you only need a few)

You don't need to be right often to beat the market — you need to be right big, and the math is less mysterious than most investors think.

The math of one 10x stock

Imagine a 25-stock portfolio with equal weights. Each position starts as 4% of the book. Now suppose one of them becomes a 10-bagger over five years while everything else goes absolutely nowhere — not up, not down, flat.

That single position alone now represents 40% of the original capital. The portfolio has returned roughly 36% over five years from one stock doing the work. Add a second 10x, and you're at 72% total return. Over the same period, a flat-to-sideways S&P 500 would deliver maybe 25%. You've beaten the index with twenty-three failures and two winners.

That is the entire philosophical case for how to find 10x stocks for long term investors: you are not trying to be right all the time. You are trying to own something that, when you are right, is right by an order of magnitude. Peter Lynch built a career on this insight.

All you have to do is find a few good ones in your lifetime. You don't need a lot of winners, you need big winners.

Why diversification kills 10-baggers

Here is the uncomfortable corollary. If you own 200 stocks, no single 10-bagger meaningfully moves your portfolio. A 10x on a 0.5% position adds 4.5% of total return over the whole holding period. You have effectively neutered the one weapon that beats an index fund.

This is why truly concentrated portfolios — 15 to 40 names — have the structural capacity to outperform. Not because concentration guarantees returns; it doesn't. But because it preserves the slugging percentage on your biggest winners. Outpick runs roughly 25-35 live positions at any time, which is deliberate. For the broader argument on position count, see how many stocks you should hold to beat the market.

Patterns we look for

We've found, across a 3.8-year walk-forward backtest that produced eight doublers from 132 trades, that 10x candidates tend to share a recognizable fingerprint. None of these patterns individually guarantee anything. Together they move the odds.

• Small market cap with accelerating earnings. Hard to 10x a $500B company. Easy math on a $2B company that doubles earnings three years in a row.
• Founder-led or high insider ownership. Operators who own the business make different decisions than hired CEOs managing quarterly optics.
• Niche moat. A defensible position in a small market is worth more than an undifferentiated position in a big one.
• Ignored by sell-side. Under 5 analyst ratings, often zero. No coverage means no institutional bid, which means valuations stay reasonable.
• Post-drawdown setup. Many 10-baggers are bought after a brutal 40-60% decline when the crowd has given up but the fundamentals have quietly improved.
• Optionality. A secondary business line or geographic expansion that isn't priced in. Free upside on top of the base case.

Case study: a 5-bagger in 2 years

CRS (Carpenter Technology) is the closest thing in our live portfolio to a textbook case study. We bought it on January 2, 2024 — a small-cap specialty-alloys business that makes premium aerospace-grade materials with pricing power that most metals companies can only dream about. Two years and three months later, the position is up roughly 5x.

The fingerprint matches the pattern list almost line by line. Small-mid cap. Multi-year aerospace demand tailwind. A niche process moat in premium alloys that new entrants can't easily replicate. Barely covered by mainstream sell-side. Expanding margins that compounded into a multiple re-rating. One position does not make a strategy — but it shows the math works in live markets, not just in academic back-tests.

Across our walk-forward backtest period (June 2022 - April 2026), eight of our closed positions doubled or better. Names like YPF (+199.87%), TGS (+189.83%), BMA (+179.01%), IRS (+160.98%), and AVGO (+128.40%) made up most of the alpha. These aren't unicorns. They are the direct output of a disciplined screen applied biweekly.

The patience cost

Here is what almost no one tells you about 10x stocks: they take years. Usually three to seven. And they go down a lot on the way up. CRS had a drawdown of roughly 25% between its entry and current price. Our full portfolio had a -27.38% max drawdown in April 2025. Individual names can be worse.

Most investors who go looking for 10-baggers never actually find one because they sell during the scary parts. A position at +40% that retraces to +5% feels like a failure. Three quarters of slowing headline growth feels like the end of the thesis. You have to learn, sometimes painfully, to distinguish between a broken business and a temporary rerating.

The Outpick approach is explicit about this: we publish the thesis, the entry, and then we hold. If a position goes -30% but the fundamentals still validate the thesis, we don't touch it. That discipline is why CRS is still in the book at +470% instead of being sold at +40% two years ago. For the theory behind not trading your way out of it, see how to beat the S&P 500 without becoming a day trader.

What an actual 10x portfolio looks like

A realistic concentrated portfolio targeting asymmetric upside has a few shared characteristics. Twenty to thirty-five positions. Roughly equal starting weights, allowed to run — winners become larger by appreciation, not by rebalancing. Multi-year hold periods. Deliberate exposure to small and mid caps where the math actually allows a 10x. And a tolerance for 20-30% drawdowns at the portfolio level because that's what the upside costs.

Over our walk-forward backtest, that structure produced +38.99% CAGR against the S&P 500's +83.34% total for the same period — an alpha of +167% over 3.8 years. You can see the live portfolio on the dashboard and the full methodology on the track record page.